|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 4
Zeitschriftenartikel
Thelen, Martin; Wennhold, Kerstin; Lehmann, Jonas; Garcia-Marquez, Maria; Klein, Sebastian; Kochen, Elena; Lohneis, Philipp; Lechner, Axel; Wagener-Ryczek, Svenja; Plum, Patrick Sven; Velazquez Camacho, Oscar; Pfister, David; Doerr, Fabian; Heldwein, Matthias; Hekmat, Khosro; Beutner, Dirk; Klussmann, Jens Peter; Thangarajah, Fabinshy; Ratiu, Dominik; Malter, Wolfram; Merkelbach-Bruse, Sabine; Bruns, Christiane Josephine; Quaas, Alexander; Bergwelt-Baildon, Michael von und Schloesser, Hans A.
(2021):
Cancer-specific immune evasion and substantial heterogeneity within cancer types provide evidence for personalized immunotherapy.
In: Npj Precision Oncology, Bd. 5, Nr. 1, 52
Kruger, Stephan; Haas, Michael; Burger, Philipp Johannes; Ormanns, Steffen; Modest, Dominik Paul; Westphalen, Christoph Benedikt; Michl, Marlies; Kleespies, Axel; Angele, Martin Kurt; Hartwig, Werner; Bruns, Christiane Josephine; Niyazi, Maximilian; Roeder, Falk; Kirchner, Thomas; Werner, Jens; Heinemann, Volker und Boeck, Stefan
(2016):
Isolated pulmonary metastases define a favorable subgroup in metastatic pancreatic cancer.
In: Pancreatology, Bd. 16, Nr. 4: S. 593-598
Kruger, Stephan; Haas, Michael; Burger, Philipp Johannes; Ormanns, Steffen; Modest, Dominik Paul; Westphalen, Christoph Benedikt; Kleespies, Axel; Angele, Martin Kurt; Hartwig, Werner; Bruns, Christiane Josephine; Kirchner, Thomas; Werner, Jens; Heinemann, Volker und Boeck, Stefan
(2016):
Acinar cell carcinoma of the pancreas: a rare disease with different diagnostic and therapeutic implications than ductal adenocarcinoma.
In: Journal of Cancer Research and Clinical Oncology, Bd. 142, Nr. 12: S. 2585-2591
Zhao, Lu; Zhao, Yue; Schwarz, Bettina; Mysliwietz, Josef; Hartig, Roland; Camaj, Peter; Bao, Qi; Jauch, Karl-Walter; Guba, Makus; Ellwart, Joachim Walter; Nelson, Peter Jon und Bruns, Christiane Josephine
(2016):
Verapamil inhibits tumor progression of chemotherapy-resistant pancreatic cancer side population cells.
In: International Journal of Oncology, Bd. 49, Nr. 1: S. 99-110